Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OGI 
OrganiGram Holdings Inc (OGI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: OGI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $8.8
1 Year Target Price $8.8
| 3 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -37.68% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 231.86M USD | Price to earnings Ratio 173 | 1Y Target Price 8.8 |
Price to earnings Ratio 173 | 1Y Target Price 8.8 | ||
Volume (30-day avg) 4 | Beta 1.97 | 52 Weeks Range 0.85 - 2.00 | Updated Date 08/28/2025 |
52 Weeks Range 0.85 - 2.00 | Updated Date 08/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.01 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-08-13 | When - | Estimate -0.014 | Actual -0.05 |
Profitability
Profit Margin 3.47% | Operating Margin (TTM) -2.97% |
Management Effectiveness
Return on Assets (TTM) -5.56% | Return on Equity (TTM) -54.53% |
Valuation
Trailing PE 173 | Forward PE 208.33 | Enterprise Value 210586971 | Price to Sales(TTM) 1.04 |
Enterprise Value 210586971 | Price to Sales(TTM) 1.04 | ||
Enterprise Value to Revenue 1.26 | Enterprise Value to EBITDA 9.27 | Shares Outstanding 134022000 | Shares Floating 93855968 |
Shares Outstanding 134022000 | Shares Floating 93855968 | ||
Percent Insiders 32.26 | Percent Institutions 6.05 |
Upturn AI SWOT
OrganiGram Holdings Inc
Company Overview
History and Background
OrganiGram Holdings Inc. was founded in 2013 in Moncton, New Brunswick, Canada. It began as a medical cannabis producer and has evolved into a recreational and medical cannabis company with a focus on innovation and product diversification.
Core Business Areas
- Cannabis Cultivation and Production: OrganiGram cultivates cannabis at its indoor facility in Moncton. It uses advanced technologies for cultivation, including three-tiered growing systems and energy-efficient practices.
- Product Development and Sales: OrganiGram develops and sells a range of cannabis products, including dried flower, edibles, vape pens, concentrates, and cannabis-infused beverages. These products are distributed through various channels, including provincial and territorial cannabis retailers and medical cannabis platforms.
- International Expansion: OrganiGram is involved in international cannabis markets through strategic partnerships and investments. This includes collaborations in Australia, Germany, and other regions.
Leadership and Structure
The leadership team includes Beena Goldenberg (Chief Executive Officer), Derrick West (Chief Financial Officer), and other key executives. The company operates with a board of directors overseeing corporate governance and strategic direction.
Top Products and Market Share
Key Offerings
- Dried Flower: OrganiGram offers a variety of dried flower strains, catering to different consumer preferences. Market share data is not consistently reported but it's estimated between 5-10% in the Canadian market based on overall sales figures compared to total market data. Competitors include Canopy Growth, Tilray, and Aurora Cannabis.
- Edibles: OrganiGram produces cannabis-infused edibles, including chocolates and gummies. Market share is smaller than dried flower but is growing rapidly. Competitors in the edibles market include Wana Brands, Aurora Drift, and Bhang.
- Vapes: OrganiGram's vape products include cartridges and disposable vape pens. Competitors include Aurora, Tilray, and Auxly.
Market Dynamics
Industry Overview
The cannabis industry is characterized by rapid growth, evolving regulations, and increasing competition. The Canadian market is relatively mature, with both recreational and medical cannabis legalized. The US market is fragmented, with varying state regulations. Globally, the industry is expanding as more countries legalize or decriminalize cannabis.
Positioning
OrganiGram positions itself as a producer of high-quality, innovative cannabis products. Its indoor cultivation facility and focus on research and development are key competitive advantages. The company also emphasizes its strategic partnerships and international presence.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions by 2030. OrganiGram is positioned to capture a share of this TAM through its expansion efforts and product innovation.
Upturn SWOT Analysis
Strengths
- Advanced indoor cultivation facility
- Focus on product innovation
- Strategic partnerships
- Strong brand recognition within Canada
Weaknesses
- Smaller scale compared to larger competitors
- Reliance on the Canadian market
- Profitability challenges in a competitive market
Opportunities
- Expansion into new international markets
- Development of new cannabis-based products
- Acquisitions of smaller cannabis companies
- Further expansion in cannabis 2.0 markets such as edibles and beverages
Threats
- Increasing competition
- Regulatory changes
- Price compression
- Changing consumer preferences
Competitors and Market Share
Key Competitors
- CGC
- TLRY
- ACB
- CRON
Competitive Landscape
OrganiGram benefits from its advanced indoor cultivation facility and innovative product development, but faces challenges from larger competitors with greater financial resources and broader market reach.
Major Acquisitions
Laurentian Organic Inc.
- Year: 2024
- Acquisition Price (USD millions): 26.44
- Strategic Rationale: Acquisition of Laurentian Organic Inc. (LOI) to expand operations in premium cannabis products and innovation.
Growth Trajectory and Initiatives
Historical Growth: OrganiGram's growth has been driven by expansion in the Canadian cannabis market and strategic acquisitions.
Future Projections: Analyst estimates suggest continued revenue growth as OrganiGram expands its product offerings and international presence.
Recent Initiatives: Recent initiatives include the launch of new cannabis products, partnerships with international companies, and investments in research and development.
Summary
OrganiGram is a mid-sized cannabis company focusing on product innovation and strategic partnerships, its strong indoor cultivation facility gives it an advantage. The company is challenged by larger competitors and regulatory hurdles. Expanding international markets and focusing on high-margin products are key to their growth. Profitability remains a primary concern in a fiercely competitive sector.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
The information provided is for informational purposes only and should not be construed as investment advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OrganiGram Holdings Inc
Exchange NASDAQ | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2014-08-27 | CEO & Director Ms. Beena G. Goldenberg | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 1178 | Website https://www.organigram.ca |
Full time employees 1178 | Website https://www.organigram.ca | ||
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.